Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Natera announces first patients enrolled in Signatera-guided melanoma study
The study is a multi-center trial in advanced or metastatic melanoma sponsored by NYU Langone Health. It will use Signatera to guide treatment escalation after six weeks of first-line treatment.